1721 E 19th Ave Ste 300DenverDenver, CO 80218
Fax+1 720-754-4801
Overview of Dr. Rotta
Marcello Rotta, MD, is a double-board-certified, fellowship-trained hematologist/oncologist who helps lead the leukemia and long-term follow-up team at CBCI. He has extensive experience in the treatment of blood cancer and stem cell transplants.
Born and raised near the Alps in Torino, Italy, Dr. Rotta earned his medical degree from the University of Torino, graduating Summa Cum Laude. There, he trained in internal medicine, hematology and stem cell transplantation. Dr. Rotta’s training was furthered with a post-doctoral research fellowship At the Fred Hutchinson Cancer Research Center in Seattle and at the University of Washington; an internal medicine residency at Yale , Bridgeport Hospital program, CT; and a hematology/oncology fellowship at the James Cancer Center at Ohio State University in Columbus, OH.
Dr. Rotta’s clinical research and publication began after earning his medical degree and has never stopped. He has won awards and scholarships related to this work, been involved in several international multi-centric clinical trials as well as stem cell transplantation models in clinical research.
In his free time, Dr. Rotta is an avid hiker and biker and enjoys the Colorado outdoors with his wife and their three children.
Education & Training
Bridgeport Hospital/Yale UniversityResidency, Internal Medicine, 2011 - 2014
University of Torino Faculty of MedicineClass of 2002
Certifications & Licensure
CO State Medical License 2016 - 2027
NM State Medical License 2024 - 2027
OH State Medical License 2014 - 2018
WA State Medical License 2010 - 2011
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Ziftomenib with venetoclax and azacitidine in relapsed/refractory NPM1-mutated acute myeloid leukemia.Eunice S Wang, Harry P Erba, Amer M Zeidan, Gail J Roboz, Jessica K Altman
Blood. 2026-06-02 - 11 citationsIbrutinib for therapy of steroid-refractory chronic graft-versus-host disease: a multicenter real-world analysis.Joseph Pidala, Jongphil Kim, Denise Kalos, Corey Cutler, Zachariah DeFilipp
Blood Advances. 2025-03-11 - 1 citationsDeterminants of Outcomes for Acute Myeloid Leukemia Patients Treated in a Community-Based Specialized Versus Non-Specialized Hospital Setting.Minoo Battiwalla, Ju-Hsien Chao, Tonya Cox, Jose Carlos Cruz, William B Donnellan
Clinical Hematology International. 2024-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:










